A tale of three in symbiosis: TB-COVID-19-Bordetella coinfection

2Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Coinfections/mixed infections are common in the respiratory tract. Many times existing organisms have similar risk factors and clinical features that make the diagnosis difficult. Coronavirus diagnosed in 2019 (COVID-19) and tuberculosis (TB) are two such diseases. Patients with TB have lower cellular immunity and impaired pulmonary function. In such environment, atypical organisms, can infect and make the outcome unfavorable. A 21-year-old malnourished (body mass index-15 kg/m 2) girl presented with fever and cough for 10 days. Sputum for Cartridge Based Nucleic Acid Amplification Test demonstrated Mycobacterium tuberculosis with no rifampin resistance. Fever persisted (100-101°F) and saturation was dropping even after 10 days of antitubercular treatment. A repeat reverse transcription-polymerase chain reaction was done and was positive. In view of persistent symptoms after 20 days, bronchoscopy was done, and cultures showed Bordetella bronchiseptica. Fever and symptoms resolved completely after initiation of the sensitive drug. Diagnostic delay in coinfections can lead to increased morbidity and mortality.

Cite

CITATION STYLE

APA

Mulkoju, R. C., Rajuri, V., Leo, S., & Kolan, R. R. (2022). A tale of three in symbiosis: TB-COVID-19-Bordetella coinfection. International Journal of Mycobacteriology, 11(4), 463–465. https://doi.org/10.4103/ijmy.ijmy_166_22

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free